Literature DB >> 22771915

Association of SNP41, SNP56 and a novel SNP in PDE4D gene with stroke and its subtypes.

Anjana Munshi1, Sitara Roy, Kumarasamy Thangaraj, Subash Kaul, M Sai Babu, Akka Jyothy.   

Abstract

An association between phosphodiesterase 4D (PDE4D) gene and risk of stroke has been suggested by deCODE group in an Icelandic population. In the present case-control study we investigated the association of SNP41 (rs12153798) and SNP56 (rs702553) with ischemic stroke and stroke subtypes. Five hundred and sixteen ischemic stroke patients and 513 healthy age and sex matched controls were included in the study. The genotypes were determined by subjecting the PCR products to sequencing. Both the SNPs 56 and 41 associated significantly with stroke [adjusted OR=1.97; 95% CI (1.262-3.082); p=0.003: adjusted OR=5.42; 95% CI (3.45-8.5); p<0.001 respectively]. In addition to this, a novel SNP at position 59736747 T>G was found while sequencing the PCR products including SNP56. This novel SNP was found in patients as well as controls but did not show a significant association with the disease. We found significant association of SNPs 56 and 41 with large artery atherosclerosis, lacunar and cardioembolic stroke. In conclusion PDE4D gene plays a key part in the pathogenesis of ischemic stroke in the South Indian population from Andhra Pradesh.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771915     DOI: 10.1016/j.gene.2012.06.079

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects.

Authors:  Zhongjun Chen; Jinyu Zheng; Wenguang Liu; Kun Yang; Kai Li; Baosheng Huang; Ronglan Zhu; Xiaocheng Lu; Lixin Li
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

2.  Association of plaque enhancement on vessel wall MRI and the phosphodiesterase 4D variant with stroke recurrence in patients with symptomatic intracranial atherosclerosis.

Authors:  Chuanhui Xu; Jun Qin; Jinhui Yu; Yan Sun; Dongmin Hu; Gang Wu; Yang Li
Journal:  Neuroradiology       Date:  2022-04-14       Impact factor: 2.995

Review 3.  Stroke in South Asian countries.

Authors:  Mohammad Wasay; Ismail A Khatri; Subhash Kaul
Journal:  Nat Rev Neurol       Date:  2014-02-11       Impact factor: 42.937

4.  Phosphodiesterase 4D gene polymorphisms in sudden sensorineural hearing loss.

Authors:  Chen-Yu Chien; Shu-Yu Tai; Ling-Feng Wang; Edward Hsi; Ning-Chia Chang; Hsun-Mo Wang; Ming-Tsang Wu; Kuen-Yao Ho
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-31       Impact factor: 2.503

5.  Phosphodiesterase 4D polymorphisms associate with the short-term outcome in ischemic stroke.

Authors:  Yan-Li Song; Chun-Juan Wang; Yi-Ping Wu; Jie Lin; Peng-Lian Wang; Wan-Liang Du; Li Liu; Jin-Xi Lin; Yi-Long Wang; Yong-Jun Wang; Gai-Fen Liu
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

6.  Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway.

Authors:  Bingtian Xu; Yunyun Qin; Dan Li; Ningbo Cai; Jinling Wu; Lan Jiang; Limei Jie; Zhongzhen Zhou; Jiangping Xu; Haitao Wang
Journal:  Redox Biol       Date:  2019-10-13       Impact factor: 11.799

7.  Correlation between the single nucleotide polymorphisms of the human phosphodiesterase 4D gene and the risk of cerebral infarction in the Uygur and Han ethnic groups of Xinjiang, China.

Authors:  Jianhua Ma; Qimeng Sun; Xiaoning Zhang; Hebin DU
Journal:  Exp Ther Med       Date:  2013-10-29       Impact factor: 2.447

8.  No Association Between Single-Nucleotide Polymorphism 56 (SNP56) in Phosphodiesterase 4D (PDE4D) Gene and Susceptibility to Ischemic Stroke: A Meta-Analysis of 15 Studies.

Authors:  Xin-Yong Zhang; Qi Wan; Dong-Ya Zhu
Journal:  Med Sci Monit       Date:  2016-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.